An Official Website of the United States Government
Company Information:
Name:
ACCELERATED MEDICAL DIAGNOSTICS, LLC
Address:
2121 2ND ST, B-101
DAVIS, CA 95616-5472
DAVIS, CA 95616-5472
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Phase 0 carboplatin microdosing diagnostics trial
Award Year / Program / Phase:
2010 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Paul Henderson – (925) 570-1615
Award Amount:
$195,550.00
Abstract:
We developed a technology called PlatinDx that, based upon preclinical data, can potentially identify chemoresistance in cancer patients before they receive carboplatin or cisplatin therapy. PlatinDx utilizes tracing of subtherapeutic "microdoses" of 14C-labeled carboplatin with… More
OTHER FUNCTIONS PHASE 0 CARBOPLATIN MICRODOSING DIAGNOSTIC TRIAL.
Award Year / Program / Phase:
2012 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Paul Henderson – 925-570-1615
Award Amount:
$1,499,894.00
Abstract:
We developed a technology called PlatinDx that, based upon preclinical data, can potentially identify chemoresistance in lung and bladder cancer patients before they receive carboplatin therapy. PlatinDx utilizes tracing of subtherapeutic microdoses of14C-labeled carboplatin with accelerator… More
OTHER FUNCTIONS - RandD BIOMEDICAL (BASIC RESEARCH)
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Paul Henderson – 925-570-1615
Award Amount:
$199,969.00
Abstract:
A. Background Information We developed a technology called PlatinDx that, based upon preclinical data, can potentially identify chemoresistance in breast cancer patients before they receive oxaliplatin therapy. PlatinDx utilizes tracing of subtherapeuticmicrodoses of 14C-labeled oxaliplatin with… More